INS and type 1 diabetes mellitus: Healthy mice were injected with streptozotocin to induce type 1 diabetes (as indicated by pronounced hyperglycemia, greater >250 mg/dL) and a subset was subsequently treated with a subcutaneous insulin pump up to 8 weeks after the induction of diabetes (Figure 2A).